Lyon: JPJ Health (06618.HK) target price raised to 56 Hong Kong dollars, with steady revenue growth continuing.
Zhitong Financial APP learned that Lyon released a research report stating that JD Health (06618.HK) has adjusted upwards its net profit forecast for 2025 and 2026 by 5% and 6% respectively to reflect better cost control, and raised its target price from 45 Hong Kong dollars to 56 Hong Kong dollars. The bank pointed out that JD Health is a major beneficiary of JD Group-SW's aggressive investment in APP user growth strategy, and maintains its "outperform market" rating for JD Health.
Latest